Frailty Scores and Their Utility in Older Patients with Cardiovascular Disease

被引：36

作者：

Chung, Kenneth Jordan Ng Cheong ^{[1
,2
]}

Wilkinson, Chris ^{[1
]}

Veerasamy, Murugapathy ^{[3
,4
]}

Kunadian, Vijay ^{[1
,2
,5
]}

机构：

[1] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, Newcastle Upon Tyne, England

[2] Newcastle Upon Tyne Hosp NHS Fdn Trust, Freeman Hosp, Cardiothorac Ctr, Newcastle Upon Tyne, England

[3] Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Leeds, England

[4] Univ Leeds, Leeds Inst Cardiovasc & Metab Med, Leeds, England

[5] Newcastle Univ, Translat & Clin Res Inst, Fac Med Sci, 4th Floor William Leech Bldg,Queen Victoria Rd, Newcastle Upon Tyne NE2 4HH, England

来源：

INTERVENTIONAL CARDIOLOGY-REVIEWS RESEARCH RESOURCES | 2021年 / 16卷

关键词：

Frailty assessment; older patients; cardiovascular disease; CHD; valvular heart disease; interventional cardiology;

D O I：

10.15420/icr.2020.18

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The world's population is ageing, resulting in more people with frailty receiving treatment for cardiovascular disease (CVD). The emergence of novel interventions, such as transcatheter aortic valve implantation, has also increased the proportion of older patients being treated in later stages of life. This increasing population burden makes the assessment of frailty of utmost importance, especially in patients with CVD. Despite a growing body of evidence on the association between frailty and CVD, there is no consensus on the optimal frailty assessment tool for use in clinical settings. Previous studies have shown limited concordance between validated frailty instruments. This review evaluates the evidence on the utility of frailty assessment tools in patients with CVD, and the effect of frailty on different outcomes measured.

引用

页数：10